- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- April 2023
- 175 Pages
Global
From €5703EUR$5,899USD£4,899GBP
- Report
- June 2023
- 83 Pages
Global
From €3500EUR$3,878USD£3,112GBP
- Report
- October 2023
- 270 Pages
China
From €3867EUR$4,000USD£3,322GBP
- Report
- October 2023
- 135 Pages
China
From €1740EUR$1,800USD£1,495GBP
Cefalexin is an antibiotic used to treat a variety of bacterial infections, including those caused by Streptococcus, Staphylococcus, and E. coli. It is a member of the cephalosporin class of antibiotics, which are used to treat a wide range of infections, including those caused by Gram-positive and Gram-negative bacteria. Cefalexin is commonly used to treat infections of the respiratory tract, urinary tract, skin, and soft tissue. It is also used to treat some sexually transmitted diseases, such as gonorrhea.
Cefalexin is a widely used antibiotic in the infectious diseases drugs market. It is generally well tolerated and has a low risk of side effects. It is available in both oral and intravenous forms, and is often prescribed as a first-line treatment for bacterial infections.
Some companies in the Cefalexin market include Pfizer, GlaxoSmithKline, Merck, and Sanofi. Show Less Read more